M-CERSI Conference on Patient-Focused Drug Development
Monday, March 9, 2015
8:30 a.m.-5:00 p.m.
Hyatt Regency Hotel, Bethesda, MD
For More Information:
301 405 0285
About the Event:
The M-CERSI Conference on Patient-Focused Drug Development will be held on Monday, March 9, 2015 at the Hyatt Regency Hotel in Bethesda, MD. The conference will provide a forum for all patient-focused drug development (PFDD) stakeholders to gather for an open dialogue. Patients, caregivers, and patient advocacy groups, as well as regulators from the Food and Drug Administration (FDA); researchers from academia, industry, and other agencies; payers; and other stakeholders will come together to discuss the following topics:
- Definition of PFDD
- Essential components that need to be included in successful PFDD
- Current initiatives, such as those of the FDA, patient advocacy groups, and pharmaceutical companies
- Challenges to achieving PFDD and methods to overcome those challenges
- Recommendations on a plan of action that includes a description of stakeholders' roles to move PFDD forward
Workshop will examine current practices and applications of pediatric exposure matching and pediatric exposure-response analysis from variety of perspectives with special attention to recommendations for application of these practices in drug development.
For additional information: http://www.pharmacy.umaryland.edu/centers/cersievents/patient-focused-drug-development/